Skip to search formSkip to main contentSkip to account menu

Neuromuscular Blocking Agents

Known as: blockers neuromuscular, neuromuscular blocker, [MS300] NEUROMUSCULAR BLOCKING AGENTS 
Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Objective To determine whether use of intermediate acting neuromuscular blocking agents during general anesthesia increases the… 
Highly Cited
2010
Highly Cited
2010
BACKGROUND Postoperative residual curarization (PORC) [train-of-four ratio (T4/T1) <0.9] is associated with increased morbidity… 
Review
2009
Review
2009
The use of anticholinesterases to reverse residual neuromuscular block is efficacious only if recovery is already established. It… 
Review
2005
Review
2005
BACKGROUND To avoid postoperative residual neuromuscular block there is a need for a change in clinician's attitude towards… 
Highly Cited
2004
Highly Cited
2004
ObjectiveTo evaluate the effects of a 48-hr neuromuscular blocking agents (NMBA) infusion on gas exchange over a 120-hr time… 
Highly Cited
1994
Highly Cited
1994
The long‐term use of nondepolarizing neuromuscular blocking agents (ND‐NMBA) has recently been implicated as a cause of prolonged… 
Review
1992
Review
1992
Multiple factors alter the interaction of muscle relaxants with the NMJ. This review has focused on the aberrant responses caused… 
Highly Cited
1978
Highly Cited
1978
THE cholinesterase (ChE) of skeletal muscle is concentrated at the neuromuscular junction, where it hydrolyses acetylcholine… 
Highly Cited
1972
Highly Cited
1972
The number of acetylcholine receptors per motor end plate in the rat diaphragm, measured by the binding of [1251]α-bungarotoxin…